Passage Bio, Inc. logo

Passage Bio, Inc.

NASDAQ:PASG

Overview | Financials
Company Name Passage Bio, Inc.
Symbol PASG
Currency USD
Price 0.596
Market Cap 36,813,311
Dividend Yield 0%
52-week-range 0.54 - 1.79
Industry Biotechnology
Sector Healthcare
CEO Dr. William Chou M.D.
Website https://www.passagebio.com

An error occurred while fetching data.

About Passage Bio, Inc.

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to

Related Stocks

NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.

NRXP

1.265 USD

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.

EVLO

0 USD

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.

ELEV

0.551 USD

Precision BioSciences, Inc. logo

Precision BioSciences, Inc.

DTIL

8.96 USD

Financials

Numbers are in millions USD

Numbers are in millions USD